Aliases & Classifications for Filariasis

About this section

Aliases & Descriptions for Filariasis:

Name: Filariasis 11 50 39 13 68
 
Disease Due to Superfamily Filarioidea 11

Classifications:



External Ids:

Disease Ontology11 DOID:1080
ICD9CM32 125.9
MeSH39 D005368
NCIt45 C34611

Summaries for Filariasis

About this section
Disease Ontology:11 A parasitic helminthiasis infectious disease that involves parasitic infection of the lymphatics and subcutaneous tissue by nematodes of the superfamily Filarioidea.

MalaCards based summary: Filariasis, also known as disease due to superfamily filarioidea, is related to lymphedema and thelaziasis, and has symptoms including discharge from eye An important gene associated with Filariasis is IL5 (Interleukin 5), and among its related pathways are IL-9 Signaling Pathways and their Primary Biological Effects in Different Immune Cell Types and Inflammatory Response Pathway. Affiliated tissues include testes, breast and t cells, and related mouse phenotypes are integument and renal/urinary system.

Wikipedia:71 Filariasis is a parasitic disease caused by an infection with roundworms of the Filarioidea type. These... more...

Related Diseases for Filariasis

About this section

Diseases related to Filariasis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 368)
idRelated DiseaseScoreTop Affiliating Genes
1lymphedema31.0ALB, IL10, IL6, TNF
2thelaziasis30.0IFNG, IL10
3panuveitis29.7CTLA4, IL10, TNF
4toxocariasis29.6IFNG, TLR2, TLR4, TLR9
5babesiosis29.3IL10, IL6, TNF
6rheumatoid arthritis26.9CCL5, CTLA4, IFNG, IL10, IL2, IL6
7malaria25.5ALB, CCL5, CHIT1, CTLA4, IFNG, IL10
8filarial elephantiasis11.9
9loiasis11.8
10dirofilariasis11.3
11elephantiasis11.2
12onchocerciasis11.2
13mansonelliasis11.1
14podoconiosis11.1
15setariasis10.7
16dipetalonemiasis10.7
17pulmonary interstitial glycogenosis10.6IL10, TLR4
18sinonasal undifferentiated carcinoma10.6TLR2, TLR4
19rickettsialpox10.6TLR2, TLR4
20gastroschisis abdominal wall defects, included10.6IFNG, IL5
21atrial septal defect coronary sinus10.6TLR2, TLR4
22eye accommodation disease10.6IFNG, IL10
23pernicious anemia10.5IL10, TLR2, TLR4
24piepkorn karp hickok syndrome10.5IL10, TNF
256q terminal deletion syndrome10.5IL10, TNF
26linitis plastica10.5IL2, TNF
27pediatric t-cell leukemia10.5IL10, IL2
28thomsen and becker disease10.4IFNG, IL2, IL5
29bulbospinal polio10.4IFNG, IL2, TLR4
30anthracosilicosis10.4IFNG, IL2
31askin's tumor10.4IFNG, IL10, TLR2
32basidiobolomycosis10.4IL10, TNF
33paralytic lagophthalmos10.4IL10, TNF
34acute interstitial pneumonia10.4IL10, IL5
35acute gonococcal salpingitis10.4CTLA4, IFNG, IL5
36tetanus neonatorum10.4IFNG, IL10, IL5
37neurogenic bladder10.4TLR4, TNF
38tarsal tunnel syndrome10.4IL5, IL6
39collagen disease10.4IFNG, IL10, IL2
40baetz-greenwalt syndrome10.4IFNG, TNF
41predominantly cortical thymoma10.4IL10, IL6
42spondylohypoplasia, arthrogryposis and popliteal pterygium10.4TLR2, TLR4, TNF
43inner ear cancer10.4TLR2, TLR4, TNF
44orofaciodigital syndrome iv10.4CTLA4, IL10, IL2
45krieble bixler syndrome10.4CTLA4, TNF
46cd3zeta deficiency10.4CTLA4, IFNG, IL2
47alkhurma hemorrhagic fever10.4IL10, TLR2, TNF
48autoimmune pancreatitis10.3IFNG, TNF
49acute cholangitis10.3TLR2, TLR4, TNF
50nasopharyngitis10.3TLR2, TLR4, TNF

Graphical network of the top 20 diseases related to Filariasis:



Diseases related to filariasis

Symptoms & Phenotypes for Filariasis

About this section

UMLS symptoms related to Filariasis:


discharge from eye

MGI Mouse Phenotypes related to Filariasis according to GeneCards Suite gene sharing:

41 (show all 14)
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00107718.8CTLA4, IFNG, IL10, IL6, TLR2, TLR4
2MP:00053678.5ALB, IFNG, IL6, TLR2, TLR4, TLR9
3MP:00053858.5CTLA4, IFNG, IL10, IL2, IL6, TLR2
4MP:00053898.5IFNG, IL10, IL2, IL5, IL6, TLR4
5MP:00053698.3ALB, IFNG, IL10, IL6, TLR2, TLR4
6MP:00053798.0ALB, CTLA4, IFNG, IL10, IL2, IL6
7MP:00020067.8ALB, IFNG, IL10, IL2, IL5, IL6
8MP:00053847.6ALB, IFNG, IL10, IL2, IL6, TLR2
9MP:00053887.4CTLA4, IFNG, IL10, IL2, IL5, IL6
10MP:00053707.4ALB, CTLA4, IFNG, IL10, IL2, IL5
11MP:00053816.9ALB, CTLA4, IFNG, IL10, IL2, IL5
12MP:00053766.9ALB, CTLA4, IFNG, IL10, IL2, IL5
13MP:00053976.4CCL5, CTLA4, IFNG, IL10, IL2, IL5
14MP:00053876.1CCL5, CHIT1, CTLA4, IFNG, IL10, IL2

Drugs & Therapeutics for Filariasis

About this section

Drugs for Filariasis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 43)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
Ivermectinapproved, vet_approvedPhase 4, Phase 2, Phase 3, Phase 15770288-86-76474909, 46936176
Synonyms:
(2aE,4E,5'S,6S,6'R,7S,8E,11R,13R,15S,17aR,20R,20aR,20bS)-20,20b-dihydroxy-5',6,8,19-tetramethyl-6'-[(1S)-1-methylpropyl]-17-oxo-3',4',5',6,6',10,11,14,15,17,17a,20,20a,20b-tetradecahydro-2H,7H-spiro[11,15-methanofuro[4,3,2-pq][2,6]benzodioxacyclooctadecine-13,2'-pyran]-7-yl 2,6-dideoxy-4-O-(2,6-dideoxy-3-O-methyl-alpha-L-arabino-hexopyranosyl)-3-O-methyl-alpha-L-arabino-hexopyranoside
22,23-Dihydroxy-avermectin B
22,23-Dihyroavermectin B1
5-O-Demethyl-22,23-dihydro-avermectin A1a
71827-03-7
AB00513813
AC1MJ4GR
AC1N7O27
BPBio1_000322
BRD-K24652731-001-02-7
BSPBio_000292
CHEMBL341047
CID11957587
CID4330618
CID6321424
CID6419971
CID6427057
EU-0100693
FT-0082656
HMS1568O14
 
HMS2089M09
I 8898
I8898_SIGMA
IVERMECTIN
Ivermectin
Ivermectina
Ivermectine
Ivermectinum
Lopac0_000693
MK-933
MLS001333247
MLS001333248
MLS002153248
MolPort-006-394-715
NCGC00094047-01
NCGC00094047-02
NCGC00094047-03
Prestwick2_000156
Prestwick3_000156
Prestwick_516
S1351_Selleck
SMR000857211
2
Diethylcarbamazineapproved, vet_approvedPhase 4, Phase 2, Phase 11490-89-13052
Synonyms:
1-Diethylcarbamyl-4-methylpiperazine
12672-34-3
1642-54-2 (citrate (1:1))
4-23-00-00225 (Beilstein Handbook Reference)
5348-97-0
5348-97-0 (mono-hydrochloride)
8028-18-0
84L
90-89-1
AB00053457
AC1L1F2E
AI3-19612
AKOS003268016
BPBio1_000208
BRD-K45542189-048-05-6
BRN 0143029
BSPBio_000188
BSPBio_002179
Bitirazine
C07968
CHEMBL684
CID3052
Camin
Camin (TN)
Caracide
Carbamazine
Carbilazine
Caricide
Cypip
D07825
DB00711
Decacide
Diaethylcarbamazinum
Diethyl carbamazine
Diethylcarbamazin
Diethylcarbamazine (INN)
Diethylcarbamazine [INN:BAN]
Diethylcarbamazinum
Diethylcarbamazinum [INN-Latin]
 
Dietilcarbamazina
Dietilcarbamazina [INN-Spanish]
Ditrazine Base
Ditrazine base
DivK1c_000548
Diéthylcarbamazine
EINECS 202-023-3
Ethodryl
FR-1031
IDI1_000548
KBio1_000548
KBio2_001418
KBio2_003986
KBio2_006554
KBio3_001399
KBioGR_001081
KBioSS_001418
LS-110688
Luxuran
MolPort-001-788-448
N,N-Diethyl-4-methyl-1-piperazinecarboxamide
N,N-diethyl-4-methylpiperazine-1-carboxamide
NCGC00178778-01
NCGC00178778-02
NINDS_000548
NSC1364
Notezine
Prestwick0_000284
Prestwick1_000284
Prestwick2_000284
Prestwick3_000284
SPBio_001203
SPBio_002407
Spatonin
Spectrum2_001022
Spectrum3_000390
Spectrum4_000511
Spectrum5_000877
Spectrum_000938
UNII-V867Q8X3ZD
diethylcarbamazine
3
Albendazoleapproved, vet_approvedPhase 4, Phase 2, Phase 3, Phase 18054965-21-82082
Synonyms:
((Propylthio)-5 1H-benzimidazolyl-2) carbamate de methyle
((Propylthio)-5 1H-benzimidazolyl-2) carbamate de methyle [French]
(5-(Propylthio)-1H-benzimidazol-2-yl)carbamic acid methyl ester
(5-Propylsulfanyl-1H-benzoimidazol-2-yl)-carbamic acid methyl ester
5-(Propylthio)-2-carbomethoxyaminobenzimidazole
54965-21-8
A4673_FLUKA
A4673_SIGMA
AB00052377
AC-015
AC1L1CVL
AC1Q2YKD
AKOS000540882
Albendazol
Albendazol [INN-Spanish]
Albendazole
Albendazole (JAN/USP/INN)
Albendazole Armstrong Brand
Albendazole Diba Brand
Albendazole Fustery Brand
Albendazole Hormona Brand
Albendazole Liferpal Brand
Albendazole Monohydrochloride
Albendazole Noe-Socopharm Brand
Albendazole Pfizer Brand
Albendazole Sanicoopa Brand
Albendazole Valdecasas Brand
Albendazole [USAN:INN:BAN:JAN]
Albendazolum
Albendazolum [INN-Latin]
Albendoral
Albenza
Albenza (TN)
Albenza, Eskazole, Zentel, Andazol, Albendazole
Armstrong Brand of Albendazole
BAS 00439961
BB_SC-1386
BIDD:GT0615
BIM-0051849.0001
BPBio1_000038
BRD-K79131256-001-04-7
BSPBio_000034
BSPBio_002548
Bendapar
Bilutac
C01779
CARBAMIC ACID, (5-(PROPYLTHIO)-1H-BENZIMIDAZOL-2-YL)-, METHYL ESTER
CAS-54965-21-8
CHEBI:16664
CHEBI:506787
CHEMBL1483
CID2082
CPD000036735
Carbamic acid, [5-(propylthio)-1H-benzimidazol-2-yl]-, methyl ester
ChemDiv1_000190
ChemDivAM_000003
D00134
D015766
DB00518
Diba Brand of Albendazole
Digezanol
Disthelm
Disthelm, Mediamix V
DivK1c_000704
EINECS 259-414-7
Endoplus
Eskazole
Fustery Brand of Albendazole
Gascop
HMS1568B16
HMS1922K04
HMS2090G19
HMS2093K13
HMS502D06
HMS587I14
HSDB 7444
Hormona Brand of Albendazole
I01-0380
IDI1_000704
InChI=1/C12H15N3O2S/c1-3-6-18-8-4-5-9-10(7-8)14-11(13-9)15-12(16)17-2/h4-5,7H,3,6H2,1-2H3,(H2,13,14,15,16)
KBio1_000704
 
KBio2_002012
KBio2_004580
KBio2_007148
KBioGR_000801
KBioSS_002012
LS-50618
Liferpal Brand of Albendazole
Lurdex
MLS000069722
Mediamix V Disthelm
Methyl 5-(propyl-thio)-2-benzimidazolecarbamate
Methyl 5-(propylthio)-2-benzimidazolecarbamate
Methyl [5-(Propylthio)benzimidazol-2-yl]carbamate
Methyl-5-[propylthio]-2-benzimidazole carbamate
Metiazol
MolPort-000-726-929
MolPort-000-760-571
MolPort-001-932-918
Monohydrochloride, Albendazole
NCGC00016876-01
NCGC00016876-02
NCGC00022896-03
NCGC00022896-04
NCGC00022896-05
NCGC00022896-06
NCGC00022896-07
NINDS_000704
NSC 220008
NSC220008
Noe Socopharm Brand of Albendazole
Noe-Socopharm Brand of Albendazole
O-Methyl N-(5-(propylthio)-2-benzimidazolyl)carbamate
Oprea1_429292
Oprea1_585016
Oprea1_640007
Pfizer Brand of Albendazole
Prestwick0_000247
Prestwick1_000247
Prestwick2_000247
Prestwick3_000247
Prestwick_675
Proftril
Ricobendazole
Rycobendazole
S1640_Selleck
SAM002589939
SK&F 62979
SK&F-62979
SK&F62979
SKF 62979
SKF-62979
SKF62979
SMR000036735
SPBio_002253
SPECTRUM1503903
STK387550
STL046130
STOCK2S-67946
Sanicoopa Brand of Albendazole
Smith Kline & French Brand of Albendazole
SmithKline Beecham Brand of Albendazole
Spectrum4_000201
Spectrum5_001567
Spectrum_001532
TL8003543
UNII-F4216019LN
V Disthelm, Mediamix
VU0239747-6
Valbazen
Valdecasas Brand of Albendazole
ZINC17146904
Zental
Zentel
[5-(Propylthio)benzimidazol-2-yl]carbamic Acid Methyl Ester
[5-(Propythio)-1H-benzimidazol-2-yl]carbamic acid methyl ester
albendazole
methyl N-(6-propylsulfanyl-1H-benzimidazol-2-yl)carbamate
methyl N-[6-(propylsulfanyl)-1H-1,3-benzodiazol-2-yl]carbamate
methyl [(2Z)-5-(propylsulfanyl)-1,3-dihydro-2H-benzimidazol-2-ylidene]carbamate
methyl [5-(propylsulfanyl)-1H-benzimidazol-2-yl]carbamate
methyl [5-(propylthio)-1H-benzimidazol-2-yl]carbamate
methyl [6-(propylsulfanyl)-1H-benzimidazol-2-yl]carbamate
4
Doxycyclineapproved, investigational, vet_approvedPhase 4, Phase 3, Phase 2237564-25-054671203
Synonyms:
(2E,4S,4aR,5S,5aR,6R,12aS)-2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione
(2Z)-2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione
(2Z,4S,4aR,5S,5aR,6R)-2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione
(2Z,4S,4aR,5S,5aR,6R,12aS)-2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione
(4S,4aR,5S,5aR,6R,12aS)-4-(dimethylamino)-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide
10597-92-9
17086-28-1 (mono-hydrate)
2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-, (4S,4aR,5S,5aR,6R,12aS)
24390-14-5
41411-66-9 (6-epimer, mono-hydrochloride)
5-Hydroxy-alpha-6-deoxytetracycline
5-hydroxy-α-6-deoxytetracycline
564-25-0
6-Deoxyoxytetracycline
6-Deoxytetracycline
6-alpha-Deoxy-5-oxytetracycline
6-alpha-deoxy-5-oxytetracycline
69935-17-7 (mono-hydrochloride, di-hydrate)
6alpha-Deoxy-5-oxytetracycline
6alpha-deoxy-5-oxytetracycline
6α-deoxy-5-oxytetracycline
7164-70-7
7264-10-0
94088-85-4 (calcium salt (1:2))
AB08 (*Fosfatex)
AC1NQXW7
AC1NS4CW
AC1NUYS8
AC1O8PYM
Alti-Doxycycline
Anhydrous doxycycline
Apo-Doxy
Atridox
Azudoxat
BCBcMAP01_000024
BIDD:GT0146
BMY-28689
BPBio1_000951
BSPBio_000863
BSPBio_001936
BU-3839T
C06973
CHEBI:50845
CHEMBL1433
CID5281011
CID5353597
CID5463943
CID6713981
CPD001550033
D07876
DB00254
DMSC (*Fosfatex)
DOXCYCLINE ANHYDROUS
DOXY
DOXYCYCLINE CALCIUM
DOXYCYCLINE MONOHYDRATE
Deoxymykoin
DivK1c_000345
Dossiciclina
Dossiciclina [DCIT]
Doxcycline anhydrous
Doxiciclina
Doxiciclina [INN-Spanish]
Doxiciclina [Italian]
Doxitard
Doxivetin
Doxy-Caps
Doxy-Puren
Doxy-Tabs
Doxycen
Doxychel
Doxychel (TN)
Doxycin
Doxycyclin
Doxycycline (200mg/day) or Placebo
 
Doxycycline (INN)
Doxycycline (TN)
Doxycycline (anhydrous)
Doxycycline (internal use)
Doxycycline Hyclate
Doxycycline Monohydrate
Doxycycline anhydrous
Doxycycline hyclate
Doxycycline-Chinoin
Doxycyclinum
Doxycyclinum [INN-Latin]
Doxysol
Doxytec
Doxytetracycline
EINECS 209-271-1
GS-3065 (*monohydrate)
HMS2090E06
HSDB 3071
Hydramycin
IDI1_000345
Investin
Jenacyclin
KBio1_000345
KBio2_001287
KBio2_003855
KBio2_006423
KBio3_001156
KBioGR_001133
KBioSS_001287
LS-187766
LS-93868
Liviatin
Lopac0_000405
MolPort-002-507-423
Monodox
Monodox (*monohydrate)
NCGC00161602-01
NCGC00161602-03
NCGC00161602-04
NCGC00167961-01
NCGC00179395-01
NINDS_000345
NSC633557
Novo-Doxylin
Nu-Doxycycline
Oracea
Prestwick0_000852
Prestwick1_000852
Prestwick2_000852
Prestwick3_000852
Ronaxan
SAM002589932
SMP1_000107
SPBio_000246
SPBio_002784
STOCK1N-34341
Spanor
Spectrum2_000143
Spectrum3_000408
Spectrum4_000527
Spectrum5_000947
Spectrum_000807
Supracyclin
UNII-334895S862
UPCMLD-DP021
UPCMLD-DP021:001
Vibra-tabs
Vibramycin
Vibramycin (*monohydrate)
Vibramycin Novum
Vibramycine
Vibravenos
Vivox (*Hyclate)
alpha-6-Deoxy-5-hydroxytetracycline
alpha-6-Deoxyoxytetracycline
alpha-Doxycycline
doxycycline
5
AzithromycinapprovedPhase 4, Phase 233383905-01-555185, 53477736, 447043
Synonyms:
(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-11-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-3,4,10-trihydroxy-13-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,6,8,10,12,14-heptamethyl-1-oxa-6-azacyclopentadecan-15-one
(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-13-((2,6-Dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranosyl)oxy)-2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-11-((3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyl)oxy)-1-oxa-6-azacyclopentadecan-15-one
(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-15-oxo-11-{[3,4,6-trideoxy-3-(dimethylamino)-b-D-xylo-hexopyranosyl]oxy}-1-oxa-6-azacyclopentadecan-13-yl 2,6-dideoxy-3-C-methyl-3-O-methyl-a-L-ribo-hexopyranoside
(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-15-oxo-11-{[3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyl]oxy}-1-oxa-6-azacyclopentadecan-13-yl 2,6-dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranoside
(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)13-((2,6-Dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranosyl)oxy)-2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-11-((3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyl)oxy)-1-oxa-6-azacyclopentadecan-15-one
1-Oxa-6-azacyclopentadecan-15-one, 13-((2,6-dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranosyl)oxy)-2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-11-((3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyl)oxy)-,(2R-(2R*,3S*
121470-24-4
75199_FLUKA
83905-01-5
9-Deoxo-9a-aza-9a-methyl-9a-homoerythromycin A
AC-16014
AC1L9KEG
Aritromicina
Azasite
Azenil
Azifast
Azigram
Azimakrol
Azithramycine
Azithromycin
Azithromycin & Tumor Necrosis Factor
Azithromycin (AIDS Initiative)
Azithromycin (anhydrous)
Azithromycin Dihydrate
Azithromycin Monohydrate
Azithromycin Sterile
Azithromycin dihydrate
Azithromycin plus Tumor Necrosis Factor
Azithromycine
Azithromycine [French]
Azithromycinum
Azithromycinum [Latin]
Azitrocin
Azitromax
Azitromicina
Azitromicina [Spanish]
Azitromin
Azythromycin
BIDD:GT0792
BRN 5387583
BSPBio_002285
Bio-0676
C38H72N2O12
CCRIS 1961
CHEBI:2955
CHEMBL529
CID447043
CP-62993
CP62,993
CPD000471864
DCH3
DRG-0104
 
DivK1c_000233
HMS1922G12
HMS2094M11
HMS500L15
HSDB 7205
Hemomycin
IDI1_000233
KBio1_000233
KBio2_000787
KBio2_003355
KBio2_005923
KBio3_001505
KBioGR_000731
KBioSS_000787
LS-1834
MLS001055353
MLS001066331
MLS001201763
MLS001304005
MLS001332499
MLS001332500
Misultina
MolPort-002-507-426
N,N-Dimethyl-4-amino-benzaldehyde
NCGC00090753-01
NCGC00090753-02
NINDS_000233
NSC643732
SAM002589961
SMR000471864
SPBio_001544
SPECTRUM1503679
Spectrum2_001582
Spectrum3_000653
Spectrum4_000186
Spectrum5_001867
Spectrum_000307
Sumamed
Tromix
UNII-JTE4MNN1MD
XZ-450
Z-Pak
ZIT
Zentavion
Zithromac
Zithromax
Zithromax IV
Zithromycin
Zitromax
Zitromax Avium 600
Zmas
Zmax
azithromycin
6
Praziquantelapproved, vet_approvedPhase 43755268-74-14891
Synonyms:
(.+-)-2-(Cyclohexylcarbonyl)-1,2,3,6,7,11b-hexahydro-4H-pyrazino(2,1a)isoquinolin-4-one
(11bS)-2-(cyclohexylcarbonyl)-1,2,3,6,7,11b-hexahydro-4H-pyrazino[2,1-a]isoquinolin-4-one
135526-78-2
2-(Cyclohexylcarbonyl)-1,2,3,6,7,11b-hexahydro- 4H-pyrazino[2,1-a]-isoquinolin-4-one
2-(Cyclohexylcarbonyl)-1,2,3,6,7,11b-hexahydro-4H-pyrazino(2,1-a)isoquinolin-4-one
2-(Cyclohexylcarbonyl)-1,2,3,6,7-11b-hexahydro-4H-pyrazino(2,1a)isoquinolin-4-one
2-(Cyclohexylcarbonyl)-1,2,3,6,7-11b-hexahydro-4H-pyrazinoe(2,1a)isoquinolin-4-one
2-(cyclohexanecarbonyl)-3,6,7,11b-tetrahydro-1H-pyrazino[2,1-a]isoquinolin-4-one
2-(cyclohexylcarbonyl)-1,2,3,6,7,11b-hexahydro-4H-pyrazino[2,1-a]isoquinolin-4-one
2-Cyclohexanecarbonyl-1,2,3,6,7,11b-hexahydro-pyrazino[2,1-a]isoquinolin-4-one
2-Cyclohexylcarbonyl-1,2,3,6,7,11b-hexahydro-4H-pyrazino(2,1-a) isoquinolin-4-one
46648_FLUKA
46648_RIEDEL
5-24-03-00361 (Beilstein Handbook Reference)
55268-74-1
57452-31-0
8440, EMBAY
AB00052075
AC-11670
AC1L1J6N
AKOS000541869
Azinox
BAS 00347357
BPBio1_000088
BRD-A21858158-001-05-2
BRN 0761557
BSPBio_000080
BSPBio_002199
Bay-8440
Bayer Brand of Praziquantel
Biliricide
Biltricide
Biltricide (TN)
Biltricide, Droncit, Praziquantel
Bio-0456
C07367
CCRIS 4114
CHEMBL976
CID4891
CPD000037139
Cesol
Cisticid
Cutter
Cutter Tape Tabs
Cysticide
D00471
D011223
DB01058
DivK1c_000130
Droncit
Drontsit
EINECS 259-559-6
EINECS 260-741-2
EMBAY-8440
EU-0100909
Embay 8440
HMS1568D22
HMS1920J06
HMS2090J19
 
HMS2092A09
HMS500G12
I06-0088
IDI1_000130
InChI=1/C19H24N2O2/c22-18-13-20(19(23)15-7-2-1-3-8-15)12-17-16-9-5-4-6-14(16)10-11-21(17)18/h4-6,9,15,17H,1-3,7-8,10-13H
KBio1_000130
KBio2_001599
KBio2_004167
KBio2_006735
KBio3_001699
KBioGR_000963
KBioSS_001599
LS-23174
LS-7155
Lopac0_000909
MLS000028528
MLS000038419
MLS001201812
MLS001304085
Merck Brand of Praziquantel
MolPort-001-926-470
NCGC00015818-05
NCGC00015818-11
NCGC00089733-02
NCGC00089733-03
NCGC00089733-04
NCGC00089733-05
NINDS_000130
NPFAPI-02
Oprea1_163497
P 4668
P4668_SIGMA
Prasiquantel
Praziquantel (JAN/USP/INN)
Praziquantel [USAN:INN:BAN:JAN]
Praziquantel, (+-)-Isomer
Praziquantel, (R)-Isomer
Praziquantel, (S)-Isomer
Praziquantelum
Praziquantelum [INN-Latin]
Prestwick0_000260
Prestwick1_000260
Prestwick2_000260
Prestwick3_000260
Prestwick_402
Pyquiton
S1691_Selleck
SAM002264632
SMR000037139
SPBio_001295
SPBio_002299
SPECTRUM1500494
STK030186
Spectrum2_001288
Spectrum3_000550
Spectrum4_000482
Spectrum5_001064
Spectrum_001119
Traziquantel
UNII-6490C9U457
praziquantel
7Anti-Bacterial AgentsPhase 4, Phase 3, Phase 210884
8Lipoxygenase InhibitorsPhase 4, Phase 2, Phase 177
9AntimalarialsPhase 4, Phase 3, Phase 21216
10Antiprotozoal AgentsPhase 4, Phase 2, Phase 3, Phase 11986
11Anti-Infective AgentsPhase 4, Phase 2, Phase 3, Phase 121402
12AnthelminticsPhase 4, Phase 2, Phase 3, Phase 1431
13Antimitotic AgentsPhase 4, Phase 2, Phase 3, Phase 15498
14Antiparasitic AgentsPhase 4, Phase 2, Phase 3, Phase 12127
15
PetrolatumapprovedPhase 3898009-03-8
Synonyms:
Multi-hydrocarbon
Paraffinum album
Paraffinum flavum
Petrolatum base
Petrolatum, white
 
Petrolatum,amber
Petrolatum,white
Petroleum jelly
Soft paraffin
White petrolatum
White, soft paraffin
Yellow soft paraffin
16
Glycerolexperimental, approvedPhase 322356-81-5753
Synonyms:
1,2,3-Trihydroxypropane
1,2,3-propanetriol
1,2,3-trihydroxypropane
Bulbold
Cristal
E 422
Emery 916
Glyceol Opthalgan
Glycerin
Glycerin, anhydrous
Glycerin,anhydrous
Glycerine
Glycerinum
 
Glyceritol
Glycerol
Glycyl alcohol
Glyrol
Glysanin
IFP
Incorporation factor
Mackstat H 66
Monoctanoin component D
Osmoglyn
Pricerine 9091
Propanetriol
RG-S
Trihydroxypropane
Tryhydroxypropane
17MilbemycinPhase 3, Phase 27
18Sodium hypochloritePhase 342
19DisinfectantsPhase 3547
20EusolPhase 342
21Protective AgentsPhase 37190
22VitaminsPhase 35095
23
RifampinapprovedPhase 233713292-46-15458213, 5381226
Synonyms:
1-b]furan-21-yl acetate
13292-46-1
3-(((4-Methyl-1-piperazinyl)imino)-methyl)rifamycin
3-(((4-Methyl-1-piperazinyl)imino)methyl)rifamycin SV
3-(4-Methylpiperazinyliminomethyl)-rifamycin SV
3-(4-Methylpiperazinyliminomethyl)rifamycin SV
3-([(4-Methyl-1-piperazinyl)imino]methyl)rifamycin SV
3-[(4-Methyl-1-piperazinyl)iminomethyl]rifamycin SV
3-[[(4-Methyl-1-piperazinyl)imino]-methyl]rifamycin
46713_FLUKA
46713_RIEDEL
62534-43-4
8-(((4-Methyl-1-piperazinyl)imino)methyl)rifamycin SV
8-(4-Methylpiperazinyliminomethyl) rifamycin SV
8-[[(4-Methyl-1-piperazinyl)imino[methyl]rifamycin
8-[[(4-Methyl-1-piperazinyl)imino]methyl]rifamycin sv
8-[[(4-Methylpiperazinyl)imino]methyl]rifamycin sv
83907_FLUKA
83907_SIGMA
8CI)
AZT + Rifampin
Abrifam
Archidyn
Arficin
Arzide
BA-41166E
BIDD:PXR0014
BPBio1_000561
BSPBio_000509
Ba 41166
Ba 41166/E
Benemicin
Benemycin
Bio-0621
C06688
C43H58N4O12
CAS-13292-46-1
CCRIS 551
CHEBI:28077
CHEBI:455936
CHEMBL180
CID5381226
CID5388984
CID5458213
CID5702112
CID6604339
CID6708473
CID6842115
CID6912767
CID6913622
CPD001906767
D00211
DB01045
DRG-0109
Dione 21-acetate
Dipicin
DivK1c_000550
Doloresum
EINECS 236-312-0
Eremfat
Famcin
Fenampicin
HMS1569J11
HMS1920P08
HMS2089F12
HMS2092G09
HMS501L12
HSDB 3181
KBio1_000550
KBio2_000919
KBio2_003487
KBio2_006055
KBio3_003018
KBioGR_001780
KBioSS_000919
L-5103
L-5103 Lepetit
LS-7689
MLS000028552
MLS001148237
MLS001333745
MolPort-000-767-051
MolPort-002-513-586
MolPort-003-666-281
MolPort-006-395-891
NCGC00016699-01
NCGC00017365-01
NCGC00018178-01
NCGC00022678-03
NCGC00022678-04
NCGC00022678-05
NCGC00160500-01
 
NCI60_000309
NINDS_000550
NSC 113926
NSC-113926
NSC113926
Piperine & Rifampicin
Prestwick0_000525
Prestwick1_000525
Prestwick2_000525
Prestwick3_000525
Prestwick_833
R-Cin
R/AMP
R0079
R3501_SIAL
R3501_SIGMA
R5777_SIGMA
R7382_SIGMA
RAMP
RFP
RMP
Ramp
Reserpine & Rifampicin
Rf
Rfamipicin
Rifa
Rifadin
Rifadin (TN)
Rifadin I.V
Rifadin I.V.
Rifadin IV
Rifadin Iv
Rifadin, Rimactane, Rifampicin, Rifampin
Rifadine
Rifagen
Rifaldazin
Rifaldazine
Rifaldin
Rifam
Rifamicin AMP
Rifamor
Rifampicin
Rifampicin & EEP
Rifampicin & Propolis
Rifampicin (JP15/INN)
Rifampicin SV
Rifampicin [INN:BAN:JAN]
Rifampicina
Rifampicina [INN-Spanish]
Rifampicine
Rifampicine [French]
Rifampicinum
Rifampicinum [INN-Latin]
Rifampin
Rifampin (USP)
Rifampin [USAN]
Rifamsolin
Rifamycin
Rifamycin AMP
Rifamycin Amp
Rifaprodin
Rifcin
Rifinah
Rifobac
Rifoldin
Rifoldine
Riforal
Rimactan
Rimactane
Rimactane (TN)
Rimactazid
Rimactin
Rimactizid
Rimazid
Rimycin
Rofact
S1764_Selleck
SAM002264646
SMR000058322
SMR000653525
SPBio_002430
SPECTRUM1500529
STK080143
Sinerdol
Spectrum3_001837
Spectrum4_001250
Spectrum5_002018
Spectrum_000439
TNP00313
Tubocin
UNII-VJT6J7R4TR
WLN: V1 WQ A&1 E&1 E1UN- AT6N DNTJ D1
nchembio884-comp4
rifampin
24Cytochrome P-450 CYP3A InducersPhase 21101
25Nucleic Acid Synthesis InhibitorsPhase 24855
26Antitubercular AgentsPhase 21272
27Antibiotics, AntitubercularPhase 26972
28ArtemisininsPhase 2286
29ArtemisininePhase 2286
30
DihydroartemisininPhase 29471939-50-96918483
Synonyms:
(3R,5aS,6R,8aS,9R,12R,12aR)-3,6,9-trimethyldecahydro-3,12-epoxypyrano[4,3-j][1,2]benzodioxepin-10-ol
1,5,9-trimethyl-(1R,4S,5R,8S,9R,10S,12R,13R)-11,14,15,16-tetraoxatetracyclo[10.3.1.04,13.08,13]hexadecan-10-ol(Dihydroartemisinin)
71939-50-9
81496-81-3
AC-2067
AC1L32PY
AC1L9UV6
Ambotz71939-50-9
Artenimol
Artenimol (INN)
CHEBI:207229
CHEMBL25164
CID107770
 
CID456410
CID6918483
Cotecxin
D07362
D3793
Dihydroartemisinin
Dihydroartemisinine
Dihydroqinghaosu
Dihydroquinghaosu
Dihydroquinghoasu
GNF-PF-5634
JAV-110
LS-64240
VM3352
[3R-(3.alpha.,5a.beta.,6.beta.,8a.beta.,9.alpha.,10.alpha.,12.beta.,12aR*)]-Decahydro-10-hydroxy-3,6,9-trimethyl-3,12-epoxy-12H-pyrano[4.3-j]-1,2-benzodioxepin
31
PiperaquinePhase 21094085-31-85079497
Synonyms:
1,3-bis(1-(7-chloro-4'-quinolyl)-4'-piperazinyl)propane
1,3-bis(4-(7'-chloro-4'-quinoline)-1-piperazine)
4,4'-(propane-1,3-diyldipiperazine-4,1-diyl)bis(7-chloroquinoline)
4085-31-8
5-23-03-00072 (Beilstein Handbook Reference)
7-chloro-4-[4-[3-[4-(7-chloroquinolin-4-yl)piperazin-1-yl]propyl]piperazin-1-yl]quinoline
83764-65-2
AC1L3UA1
AC1Q3T7B
AR-1F7471
 
BRN 0905079
C29H32Cl2N6
CHEMBL303933
CID122262
FT-0082661
I06-1673
LS-142194
Piperaquinoline
Quinoline, 4,4'-(1,3-propanediyldi-4,1-piperazinediyl)bis(7-chloro- (9CI)
Quinoline, 4,4'-(1,3-propanediyldi-4,1-piperazinediyl)bis(7-chloro-)
ST51053186
piperaquine
32ImmunoglobulinsPhase 26045
33Antibodies, MonoclonalPhase 23795
34AntibodiesPhase 26045
35Protein Kinase InhibitorsPhase 23612
36Imatinib MesylatePhase 2594123596
37
Romidepsinapproved, investigationalPhase 184128517-07-75352062
Synonyms:
(1S,4S,7Z,10S,16E,21R)-7-Ethylidene-4,21-bis(1-methylethyl)-2-oxa-12,13-dithia-5,8,20,23-tetraazabicyclo(8.7.6)tricos-16-ene-3,6,9,19,22-pentone
(1S,4S,7Z,10S,16E,21R)-7-ethylidene-4,21-di(propan-2-yl)-2-oxa-12,13-dithia-5,8,20,23-tetraazabicyclo[8.7.6]tricos-16-ene-3,6,9,19,22-pentone
(1S,4S,7Z,10S,16E,21R)-7-ethylidene-4,21-di(propan-2-yl)-2-oxa-12,13-dithia-5,8,20,23-tetrazabicyclo[8.7.6]tricos-16-ene-3,6,9,19,22-pentone
128517-07-7
AC1NS1N3
Antibiotic FR 901228
C087123
C24H36N4O6S2
CHEBI:61080
CHEMBL343448
CID5352062
Chromadax
Chromadax (TN)
Cyclo((2Z)-2-amino-2-butenoyl-L-valyl-(3S,4E)-3-hydroxy-7-mercapto-4-heptenoyl-D-valyl-D-cysteinyl), cyclic (3?5)-disulfide"
D06637
FK 228
FK-228
 
FK-901228
FK228
FR 901228
FR-901228
FR901228
HDInhib_000006
Istodax
L-Valine, N-((3S,4E)-3-hydroxy-7-mercapto-1-oxo-4-heptenyl)-D-valyl-D-cysteinyl-(2Z)-2-amino-2-butenoxyl-, (4-1)-lactone, cyclic (1-2)-disulfide
LS-161318
NSC 630176
NSC-630176
NSC630176
Probes1_000153
Probes2_000337
Romidepsin
Romidepsin (USAN)
chromodax
istodax
nchembio.313-comp2
38
Suraminapproved18145-63-15361
Synonyms:
1,3,5-Naphthalenetrisulfonic acid, 8,8'-[carbonylbis[imino-3,1-phenylenecarbonylimino(4-methyl-3,1-phenylene)carbonylimino]]bis- (9CI)
1,3,5-Naphthalenetrisulfonic acid, 8,8'-[carbonylbis[imino-3,1-phenylenecarbonylimino(4-methyl-3,1-phenylene)carbonylimino]]bis-, hexasodium salt
1,3,5-Naphthalenetrisulfonic acid, 8,8'-[ureylenebis[m-phenylenecarbonylimino(4-methyl-m-phenylene)carbonylimino]]di- (8CI)
1,3,5-Naphthalenetrisulfonic acid, 8,8'-[ureylenebis[m-phenylenecarbonylimino(4-methyl-m-phenylene)carbonylimino]]di-, hexasodium salt
129-46-4 (hexa-hydrochloride salt)
145-63-1
3-14-00-02267 (Beilstein Handbook Reference)
8,8'-(Carbonylbis(imino-3,1-phenylenecarbonylimino(4-methyl-3,1-phenylene)carbonylimino))bisnaphthalene-1,3,5-trisulphonic acid
8,8'-[CARBONYLBIS[IMINO-3,1-PHENYLENECARBONYLIMINO(4-METHYL-3,1-PHENYLENE)CARBONYLIMINO]]BIS-1,3,5-NAPHTHALENETRISULFONIC
8,8'-[CARBONYLBIS[imino-3,1-phenylenecarbonylimino(4-methyl-3,1-phenylene)carbonylimino]]bis-1,3,5-naphthalenetrisulfonic acid
8,8'-[Carbonylbis[imino-3,1-phenylenecarbonylimino(4-methyl-3,1-phenylene)carbonyl-imino]]bis-1,3,5-naphthalenetrisulfonic acid
8,8'-[Carbonylbis[imino-3,1-phenylenecarbonylimino(4-methyl-3,1-phenylene)carbonyl-imino]]bis-1,3,5-napthalenetrisulfonic acid
8,8'-[Ureylenebis[m-phenylenecarbonylimino(4-methyl-m-phenylene)carbonylimino]]di-1,3,5-naphthalenetrisulfonic acid
8,8'-[carbonylbis[imino-3,1-phenylenecarbonylimino(4-methyl-3,1-phenylene)carbonylimino]]bisnaphthalene-1,3,5-trisulphonic acid
8-[[4-methyl-3-[[3-[[3-[[2-methyl-5-[(4,6,8-trisulfonaphthalen-1-yl)carbamoyl]phenyl]carbamoyl]phenyl]carbamoylamino]benzoyl]amino]benzoyl]amino]naphthalene-1,3,5-trisulfonic acid
AC1L1K6K
Antrypol
BRN 3230873
BSPBio_002248
Bayer 205
Belganyl
C07974
C51H40N6O23S6
CHEBI:45906
CHEMBL265502
CID5361
DB04786
DivK1c_006758
EINECS 205-658-4
Farma
Farma 939
Fourneau
Germanin
Harnstoff, symmetischer der 3-aminobenzoyl-3-amino-4-methylbenzoyl-1-naphthylamin-4,6,8-trisulfonsaeure
 
KBio1_001702
KBio2_002397
KBio2_004965
KBio2_007533
KBio3_001468
KBioGR_001774
KBioSS_002402
L000585
LS-95867
Lopac0_001182
Moranyl
NCGC00163318-01
NSC 34936
NSC34936
Naganil
Naganin
Naganine
Naganol
Naganol 6 Na
Naphuride
SGCTO-001
SURAMIN SODIUM
SVR
Sodium suramin
SpecPlus_000662
Spectrum3_000724
Spectrum4_001247
Spectrum_001877
Suramin
Suramine
Suramine sodium
WLN: L66J BSWQ DSWQ GSWQ JMVR D1 CMVR CMVMR CVMR B1 EVM-JL66J BSWQ DSWQ GSWQ &-NA-6
m,m'-Ureylen-bis-(8-(m-(benzamido)-p-toluamido)naphthalin-1,3,5-trisulfonsaeure)
suramin
sym-bis(m-aminobenzoyl-m-amino-p-methylbenzoyl-1-napthylamino-4,6,8-trisulfonate) carbamide
39
Piperazineapproved, vet_approved24110-85-04837
Synonyms:
1,4-Diazacyclohexane
1,4-Diethylenediamine
1,4-Piperazine
110-85-0
14007-05-7 (unspecified hydrobromide)
142-63-2 (hexahydrate)
142-64-3 (di-hydrochloride)
14538-56-8 (phosphate[1:1])
16832-43-2 (unspecified hydrate)
1951-97-9 (unspecified phosphate)
3597-26-0 (unspecified sulfate)
5-23-01-00030 (Beilstein Handbook Reference)
6094-40-2 (unspecified hydrochloride)
7542-23-6 (mono-hydrochloride)
8017-90-1
8027-81-4
8057-14-5 (unspecified salt)
80621_FLUKA
854880-15-2
861800-35-3
AB1003720
AC1L1J2E
AC1Q1IA7
AC1Q1IA8
AC1Q1IA9
AKOS000269028
AR-1L1009
ARONIS23910
Anthalazine
Antiren
Asca-Trol No. 3
BIDD:GT0273
BRN 0102555
C07973
CCRIS 5950
CHEBI:28568
CHEMBL1412
CID4837
D00807
DB00592
Diethylenediamine
Diethyleneimine
Dispermine
DivK1c_000038
EINECS 203-808-3
Eraverm
Eraverm (VAN)
Fluphenazine dihydrochloride
HMS1920H20
HMS2092A03
HMS500B20
HSDB 1093
Hexahydro-1,4-diazine
Hexahydropyrazine
I14-11172
IDI1_000038
InChI=1/C4H10N2/c1-2-6-4-3-5-1/h5-6H,1-4H
Jsp000824
KBio1_000038
KBio2_001593
KBio2_004161
KBio2_006729
KBioSS_001593
LS-517
LTBB000432
Lumbrical
MolPort-000-872-010
NCGC00094762-01
NCGC00094762-02
NCIOpen2_000984
NCIOpen2_000988
NCIOpen2_001024
NCIOpen2_001031
NCIOpen2_001033
NCIOpen2_001071
 
NCIOpen2_001073
NCIOpen2_001111
NCIOpen2_001151
NCIOpen2_001231
NCIOpen2_001262
NCIOpen2_001269
NCIOpen2_004830
NCIOpen2_004834
NCIOpen2_004862
NCIOpen2_004874
NCIOpen2_004904
NCIOpen2_004910
NCIOpen2_004914
NCIOpen2_004942
NCIOpen2_004952
NCIOpen2_004954
NCIOpen2_004982
NCIOpen2_004992
NCIOpen2_004994
NCIOpen2_005022
NCIOpen2_005032
NCIOpen2_005034
NCIOpen2_005062
NCIOpen2_005072
NCIOpen2_005102
NCIOpen2_005108
NCIOpen2_005145
NCIOpen2_005182
NCIOpen2_005185
NCIOpen2_005187
NCIOpen2_005200
NCIOpen2_005575
NCIOpen2_005980
NCIOpen2_009422
NINDS_000038
NSC 474
NSC474
P0446
P0447
P45907_SIAL
PIPERAZINE (HEXAHYDRATE)
PZE
Piperazidine
Piperazin
Piperazin [German]
Piperazin [Germany]
Piperazine (USP)
Piperazine Dihydrochloride Dihydrochloride Hydrate
Piperazine Hexa-Hydrate
Piperazine [UN2579] [Corrosive]
Piperazine [UN2579] [Corrosive]
Piperazine [USAN]
Piperazine anhydrous
Piperazine hexahydrate
Piperazine hydrate
Piperazine, anhydrous
Pipersol
Pyrazine hexahydride
Pyrazine, hexahy
SPECTRUM1500490
Spectrum5_001817
Spectrum_001113
UN2579
UNII-1RTM4PAL0V
Upixon
Uvilon
Vermex
Vermizine
Vermizine (TN)
WLN: T6M DMTJ
Worm-A-Ton
Worm-away
Wurmirazin
nchembio814-comp12
piperazine
piperazinium oleate
40
Mebendazoleapproved, vet_approved2431431-39-74030
Synonyms:
(5-Benzoyl-1H-benzimidazol-2-yl)-carbamic acid methyl ester
(5-Benzoyl-1H-benzimidazol-2-yl)carbamic acid methyl ester
(5-Benzoyl-1H-benzoimidazol-2-yl)-carbamic acid methyl ester
(5-benzoyl-1H-benzimidazol-2-yl)-carbamic acid methyl ester
2-Benzimidazolecarbamic acid, 5-benzoyl-, methyl ester
2-Benzimidazolecarbamic acid, 5-benzoyl-, methyl ester (8CI)
31431-39-7
46404_FLUKA
46404_RIEDEL
5-Benzoyl-2-benzimidazolecarbamic acid methyl ester
5-Benzoyl-2-benzimidazolecarbamic acid, methyl ester
AB00052203
AC-12064
AC1L1H98
AC1Q44DR
AKOS000539066
Abello Farmacia Brand of Mebendazole
Anti Worm
Anti-Worm
Ardeypharm Brand of Mebendazole
BAS 00341140
BIDD:GT0087
BPBio1_000257
BRD-K77987382-001-01-7
BRD-K77987382-001-06-6
BSPBio_000233
BSPBio_003178
Bantenol
Banworm
Besantin
Bio-0458
Bio-0803
Boots Brand of Mebendazole
Boots Threadworm Treatment
CAS-31431-39-7
CBDivE_010559
CCRIS 4479
CHEBI:6704
CHEMBL685
CID4030
CPD000036734
Carbamic acid, (5-benzoyl-1H-benzimidazol-2-yl)-, methyl ester
Carbamic acid, (5-benzoyl-1H-benzimidazol-2-yl)-, methyl ester (9CI)
Carbamic acid, N-(5-benzoylbenzimidazol-2-yl)-, methyl ester
D00368
D008463
DB00643
Degort's Brand of Mebendazole
Diba Brand of Mebendazole
DivK1c_000751
EINECS 250-635-4
Elfar Brand of Mebendazole
Equivurm Plus
Esteve Brand of Mebendazole
HMS1536H11
HMS1568L15
HMS1921F03
HMS2090B03
HMS2092B15
HMS502F13
HSDB 3232
Healthypharm Brand of Mebendazole
I06-2075
IDI1_000751
Janssen Brand of Mebendazole
KBio1_000751
KBio2_001778
KBio2_004346
KBio2_006914
KBio3_002398
KBioGR_000712
KBioSS_001778
LS-48951
Leidapharm Brand of Mebendazole
Lomper
M2523_FLUKA
M2523_SIGMA
MBDZ
MEBENDAZOLE, 99%
MLS000028491
Madicure
Mebendan
Mebendazol
Mebendazol [INN-Spanish]
Mebendazole (JAN/USP)
 
Mebendazole (JAN/USP/INN)
Mebendazole [USAN:INN:BAN:JAN]
Mebendazole(USAN)
Mebendazolum
Mebendazolum [INN-Latin]
Mebenoazole
Mebenvet
Mebex
Mebutar
Methyl 5-benzoyl benzimidazole-2-carbamate
Methyl 5-benzoyl-2-benzimidazolecarbamate
Methyl 5-benzoyl-2-benzimidazolylcarbamate
Methyl N-(5-benzoyl-1H-benzimidazol-2-yl)carbamate
Methyl N-(5-benzoyl-2-benzimidazolyl)carbamate
MolPort-000-765-625
MolPort-001-889-615
Mébendazole
N-(Benzoyl-5, benzimidazolyl)-2, carbamate de methyle
N-(Benzoyl-5, benzimidazolyl)-2, carbamate de methyle [French]
N-2 (5-Benzoyl-benzimidazole) carbamate de methyle
N-2 (5-Benzoyl-benzimidazole) carbamate de methyle [French]
NCGC00016806-01
NCGC00016806-02
NCGC00021698-03
NCGC00021698-04
NCGC00021698-05
NCGC00021698-06
NINDS_000751
NSC 184849
NSC184849
Norgine Brand of Mebendazole
Noverme
Oprea1_278237
Oprea1_768530
Ovitelmin
Pantelmin
Pfizer Brand of Mebendazole
Prestwick0_000217
Prestwick1_000217
Prestwick2_000217
Prestwick3_000217
Prestwick_310
Pripsen Mebendazole
Probes1_000013
Probes2_000149
R 17,635
R 17635
R-17635
R17635
SAM002548959
SMR000036734
SPBio_001442
SPBio_002154
SPECTRUM1501110
SSL Brand of Mebendazole
STK093862
Spectrum2_001401
Spectrum3_001439
Spectrum4_000416
Spectrum5_001381
Spectrum_001298
Sqworm
Streger Brand of Mebendazole
Sufil
Surfont
TL8002405
Taxandria Brand of Mebendazole
Tedec Meiji Brand of Mebendazole
Telmin
TimTec1_000869
UNII-81G6I5V05I
Vermicidin
Vermicol
Vermidil
Vermin
Vermirax
Vermox
Vermox (TN)
Verpanyl
Versid
Wormkuur
ZINC00121541
mebendazole
methyl (5-benzoyl-1H-benzimidazol-2-yl)carbamate
methyl N-(6-benzoyl-1H-1,3-benzodiazol-2-yl)carbamate
methyl N-(6-benzoyl-1H-benzimidazol-2-yl)carbamate
methyl [5-(phenylcarbonyl)-1H-benzimidazol-2-yl]carbamate
41Piperazine citrate24
42
Citric Acidnutraceutical, vet_approved110677-92-9311
Synonyms:
2-Hydroxy-1,2,3-propanetricarboxylate
2-Hydroxy-1,2,3-propanetricarboxylic acid
2-Hydroxytricarballylic acid
3-Carboxy-3-hydroxypentane-1,5-dioate
3-Carboxy-3-hydroxypentane-1,5-dioic acid
Aciletten
Anhydrous citrate
Anhydrous citric acid
Chemfill
Citraclean
 
Citrate
Citretten
Citric acid
Citro
Citronensäure
E 330
Hydrocerol A
Kyselina citronova
Suby G
Uro-trainer
beta-Hydroxytricarballylate
beta-Hydroxytricarballylic acid
43CitrateNutraceutical1106

Interventional clinical trials:

(show top 50)    (show all 51)
idNameStatusNCT IDPhase
1Impact of Albendazole -Ivermectin on Wuchereria Bancrofti in MaliCompletedNCT02784743Phase 4
2Post-treatment Effects of Ivermectin (IVM) or Diethylcarbamazine (DEC) in LoiasisCompletedNCT01593722Phase 4
3Alternate Chemotherapy Regimens for the Clearance of W.Bancrofti InfectionCompletedNCT02005653Phase 4
4Effect of Concomitant Mansonella Perstans Microfilaremia on Immune Responses Following Single Dose Praziquantel in People With SchistosomiasisRecruitingNCT02734186Phase 4
5Field Studies on the Feasibility of Interrupting the Transmission of Soil-transmitted Helminths (STH)Not yet recruitingNCT03014167Phase 4
6Safety Study of Combined Azithromycin, Ivermectin and Albendazole for Trachoma and Lymphatic FilariasisWithdrawnNCT01903057Phase 4
7Repeat Ivermectin Mass Drug Administrations for Control of Malaria: a Pilot Safety and Efficacy StudyCompletedNCT02509481Phase 2, Phase 3
8An RCT to Evaluate the Effect of a New Skin Care Regimen on SBF in Those With PodoconiosisCompletedNCT02839772Phase 3
9Study Comparing Moxidectin And Ivermectin In Subjects With Onchocerca Volvulus InfectionCompletedNCT00790998Phase 3
10A 24 Month Study to Compare Efficacy of Doxycycline vs Placebo for Improving Filarial Lymphedema in Sri LankaNot yet recruitingNCT02929134Phase 3
11A 24 Month Study to Compare Efficacy of Doxycycline vs Placebo for Improving Filarial Lymphedema in IndiaNot yet recruitingNCT02929121Phase 3
12A 24 Month Study, to Compare the Efficacy of Doxycycline vs. Placebo for Improving Filarial Lymphedema in MaliNot yet recruitingNCT02927496Phase 3
13Efficacy of Ivermectin and Albendazole Against Onchocerciasis in the Volta Region, GhanaNot yet recruitingNCT02078024Phase 3
14Effect of Albendazole Dose on Treatment of Lymphatic FilariasisCompletedNCT00511004Phase 2
15Doxycycline to Treat Mansonella Perstans Infection in Patients With and Without Lymphatic FilariasisCompletedNCT00340691Phase 2
16Effect of Albendazole Dose on Clearance of Filarial WormsCompletedNCT00339417Phase 2
17Effect of Albendazole Dose on Clearance of Filarial WormsCompletedNCT00375583Phase 2
18Efficacy and Safety of High-dose Ivermectin for Reducing Malaria Transmission: A Dose Finding StudyCompletedNCT02511353Phase 2
19Study Evaluating Orally Administered Moxidectin In Subjects With Onchocerca Volvulus InfectionCompletedNCT00300768Phase 2
20Clinical Trial of Rifampin and Azithromycin for the Treatment of River BlindnessCompletedNCT00127504Phase 2
21Concomitant Infections of Mansonella Perstans in Tuberculosis and Buruli Ulcer Disease Patients From GhanaRecruitingNCT02281643Phase 2
22Eval 3-Drug Therapy Diethylcarbamize, Albendazole and Ivermectin That Could Accelerate LF Elimination Outside of AfricaActive, not recruitingNCT01975441Phase 2
23A Randomized, Placebo-controlled, Double-blind Pilot Study of Single-dose Humanized Anti-IL5 Antibody (Reslizumab) for the Reduction of Eosinophilia Following Diethylcarbamazine Treatment of Loa Loa InfectionActive, not recruitingNCT01111305Phase 2
24Efficacy and Microfilaricidal Kinetics of Imatinib for the Treatment of Loa LoaNot yet recruitingNCT02644525Phase 2
25Pediatric Pharmacokinetics And Safety Study Of MoxidectinWithdrawnNCT01035619Phase 2
26First in Man Clinical Trial of Emodepside (BAY 44-4400)RecruitingNCT02661178Phase 1
27Pharmacokinetics & Pharmacodynamics of Diethylcarbamazine (DEC)+ Albendazole (ALB) + Ivermectin (IVE)Active, not recruitingNCT02845713Phase 1
28Exhaled NO Testing in FilariasisUnknown statusNCT01628497
29Disability and Quality of Life in Patients With Lymphatic Filariasis in Rural Southern IndiaCompletedNCT01629771
30Research for Elim of FilariasisCompletedNCT00145223
31Research for Elimination of Lymphatic Filariasis (ICIDR)CompletedNCT00406627
32Interaction Between HIV and Lymphatic FilariasisCompletedNCT00295698
33Medical Implications of Coinfection With Malaria and Filariasis ParasitesCompletedNCT00471666
34Safety of the Co-administration of Three Drugs for Trachoma and Lymphatic Filariasis EliminationCompletedNCT01586169
35Evaluation of Antibacterial Soap for Treatment of Lymphedema in a Filariasis-Endemic AreaCompletedNCT00139100
36Changes in HIV Viral Load in Patients Undergoing Treatment for FilariasisCompletedNCT00344279
37Promoting Consistent Shoe Use Among Children At High Risk for PodoconiosisCompletedNCT01160523
38Immune Response Regulation in People Infected Concurrently With Malarial and Filarial ParasitesCompletedNCT00341666
39Safety and Efficacy of Drug Combinations Against Triple InfectionsCompletedNCT01050517
40Community Directed Treatment of Soil-Transmitted Helminths Among Young Children in ZambiaCompletedNCT00349323
41Study of Patients With Strongyloides Stercoralis InfectionCompletedNCT00001245
42Epidemiology and Control of Mansonella Perstans Infection in UgandaCompletedNCT00215280
43Death to Onchocerciasis and Lymphatic Filariasis (DOLF) Triple Drug Therapy for Lymphatic FilariasisRecruitingNCT02899936
44Optimization of Mass Drug Administration With Existing Drug Regimens for Lymphatic Filariasis and Onchocerciasis for Ivory Coast (DOLF-Ivory Coast)RecruitingNCT02032043
45Mass Drug Administration for Lymphatic Filariasis and Onchocerciasis for LiberiaRecruitingNCT01905436
46Effect of Filarial Infection on Immune Responses in Latent TuberculosisRecruitingNCT01547884
47Host Response to Infection and Treatment in Filarial DiseasesRecruitingNCT00001230
48Optimization of Mass Drug Administration With Existing Drug Regimens for Lymphatic Filariasis and OnchocerciasisActive, not recruitingNCT01905423
49Lymphatic Filariasis (LF) in Ivory CoastActive, not recruitingNCT02974049
50Genetic and Other Aspects of PodoconiosisNot yet recruitingNCT01939431

Search NIH Clinical Center for Filariasis


Cochrane evidence based reviews: filariasis

Genetic Tests for Filariasis

About this section

Anatomical Context for Filariasis

About this section

MalaCards organs/tissues related to Filariasis:

36
Testes, Breast, T cells, Eye, Skin, B cells, Endothelial

Publications for Filariasis

About this section

Articles related to Filariasis:

(show top 50)    (show all 702)
idTitleAuthorsYear
1
Potential Value of Triple Drug Therapy with Ivermectin, Diethylcarbamazine, and Albendazole (IDA) to Accelerate Elimination of Lymphatic Filariasis and Onchocerciasis in Africa. (28056015)
2017
2
Using Community-Level Prevalence of Loa loa Infection to Predict the Proportion of Highly-Infected Individuals: Statistical Modelling to Support Lymphatic Filariasis and Onchocerciasis Elimination Programs. (27906982)
2016
3
A Rare Case of Ovarian Filariasis in Abidjan. (27313932)
2016
4
Minocycline as a re-purposed anti-Wolbachia macrofilaricide: superiority compared with doxycycline regimens in a murine infection model of human lymphatic filariasis. (26996237)
2016
5
Unusual presentation of filariasis as an abscess: A case report. (27011444)
2016
6
Assessing Lymphatic Filariasis Data Quality in Endemic Communities in Ghana, Using the Neglected Tropical Diseases Data Quality Assessment Tool for Preventive Chemotherapy. (27028010)
2016
7
The Impact of Lymphatic Filariasis Mass Drug Administration Scaling Down on Soil-Transmitted Helminth Control in School-Age Children. Present Situation and Expected Impact from 2016 to 2020. (27992424)
2016
8
Determinants of parasite drug resistance in human lymphatic filariasis. (27858056)
2016
9
Evaluation of Lymphatic Filariasis and Onchocerciasis in Three Senegalese Districts Treated for Onchocerciasis with Ivermectin. (27926918)
2016
10
Filariasis of Stensen's Duct: An Index Case. (27867674)
2016
11
Surveillance for transmission of lymphatic filariasis in Colombo and Gampaha districts of Sri Lanka following mass drug administration. (27816936)
2016
12
Harmful traditional healing practices in the treatment of lymphatic filariasis. (27297275)
2016
13
Current Epidemiological Assessment of Bancroftian Filariasis in Tanga Region, Northeastern Tanzania. (28050171)
2016
14
Filariasis in Mandible and Maxilla: A Rare Entity-First Report of a Case. (27875706)
2016
15
Prevalence of Lymphatic Filariasis and Treatment Effectiveness of Albendazole/ Ivermectin in Individuals with HIV Co-infection in Southwest-Tanzania. (27070786)
2016
16
The health and economic benefits of the global programme to eliminate lymphatic filariasis (2000-2014). (27388873)
2016
17
I'-Cadinene, Calarene and I'-4-Carene from Kadsura heteroclita essential oil as novel larvicides against malaria, dengue and filariasis mosquitoes. (27151483)
2016
18
Global programme to eliminate lymphatic filariasis: progress report, 2015. (27758091)
2016
19
Mathematical modelling of lymphatic filariasis elimination programmes in India: required duration of mass drug administration and post-treatment level of infection indicators. (27624157)
2016
20
Diagnosis of a malayan filariasis case using a shotgun diagnostic metagenomics assay. (26879053)
2016
21
An asymptomatic inguinal swelling: Lymphatic filariasis. (27279316)
2016
22
MOSQUITO IDENTIFICATION AND MOLECULAR XENOMONITORING OF LYMPHATIC FILARIASIS IN SELECTED ENDEMIC AREAS IN GIZA AND QUALIOUBIYA GOVERNORATES, EGYPT. (27363044)
2016
23
Economic Costs and Benefits of a Community-Based Lymphedema Management Program for Lymphatic Filariasis in Odisha State, India. (27573626)
2016
24
Evaluating the Burden of Lymphedema Due to Lymphatic Filariasis in 2005 in Khurda District, Odisha State, India. (27548382)
2016
25
Intravitreal Filariasis: The Accidental Traveler. (26885575)
2016
26
Doubts over India's deadline to defeat lymphatic filariasis. (27301812)
2016
27
Sustaining Progress towards NTD Elimination: An Opportunity to Leverage Lymphatic Filariasis Elimination Programs to Interrupt Transmission of Soil-Transmitted Helminths. (27416062)
2016
28
Bilateral Testicular Metastases and Filariasis in Prostatic Adenocarcinoma. (28017535)
2016
29
Understanding the relationship between prevalence of microfilariae and antigenaemia using a model of lymphatic filariasis infection. (27198217)
2016
30
Epitope mapping of Brugia malayi ALT-2 and the development of a multi-epitope vaccine for lymphatic filariasis. (26892175)
2016
31
Reducing the population requiring interventions against lymphatic filariasis in Africa. (26874545)
2016
32
Subcutaneous filariasis in India- Possible indication of human Dirofilariasis. (27004586)
2016
33
Giant Scrotal Hydrocele and Bilateral Leg Lymphedema as Clinical Manifestation of Chronic Lymphatic Filariasis. (27840360)
2016
34
Investment success in public health: An analysis of the cost-effectiveness and cost-benefit of the Global Programme to Eliminate Lymphatic Filariasis. (27956460)
2016
35
Global elimination of lymphatic filariasis. (28012944)
2016
36
Central nervous system filariasis masquerading as a glioma: case report. (28009239)
2016
37
Identification of immunodiagnostic antigens for cerebrospinal filariasis in horses by western blot analysis. (27073332)
2016
38
Correction: Prevalence of Lymphatic Filariasis and Treatment Effectiveness of Albendazole/ Ivermectin in Individuals with HIV Co-infection in Southwest-Tanzania. (27564060)
2016
39
Successful Control of Soil-Transmitted Helminthiasis in School Age Children in Burkina Faso and an Example of Community-Based Assessment via Lymphatic Filariasis Transmission Assessment Survey. (27163294)
2016
40
Further evidence of the cross-reactivity of the Binax NOWAr Filariasis ICT cards to non-Wuchereria bancrofti filariae: experimental studies with Loa loa and Onchocerca ochengi. (27151313)
2016
41
Burden of lymphatic filariasis morbidity in an area of low endemicity in Brazil. (27427218)
2016
42
Congenital filariasis caused by Setaria bidentata (Nematoda: Filarioidea) in the red brocket deer (Mazama americana). (27788338)
2016
43
Mapping is a prerequisite for elimination of filariasis and effective targeting of filarial 'hot spots'. (27413817)
2016
44
Effectiveness of a triple-drug regimen for global elimination of lymphatic filariasis: a modelling study. (28012943)
2016
45
On the Thermal Stability of the Diethylcarbamazine-Fortified TableA Salt Used in the Control of Lymphatic Filariasis. (27397435)
2016
46
Scope of detectability of circulating antigens of human lymphatic filarial parasite Wuchereria bancrofti with smaller amount of serum by Og4C3 assay: its application in lymphatic filariasis elimination programme. (27876997)
2016
47
Can Lymphatic Filariasis Be Eliminated by 2020? (27765440)
2016
48
DILEMMAS OF COMMUNITY-DIRECTED MASS DRUG ADMINISTRATION FOR LYMPHATIC FILARIASIS CONTROL: A QUALITATIVE STUDY FROM URBAN AND RURAL TANZANIA. (27470198)
2016
49
Lymphatic Filariasis Elimination in American Samoa: Evaluation of Molecular Xenomonitoring as a Surveillance Tool in the Endgame. (27802280)
2016
50
Breast Filariasis Diagnosed by Real Time Sonographic Imaging: A Case Report. (27110331)
2016

Variations for Filariasis

About this section

Expression for genes affiliated with Filariasis

About this section
Search GEO for disease gene expression data for Filariasis.

Pathways for genes affiliated with Filariasis

About this section

Pathways related to Filariasis according to GeneCards Suite gene sharing:

(show top 50)    (show all 59)
idSuper pathwaysScoreTop Affiliating Genes
19.7IL5, IL6
29.6IFNG, IL2, IL5
3
Show member pathways
9.4IFNG, IL2, TNF
4
Show member pathways
9.4IFNG, IL6, TLR4
59.4IFNG, IL6, TLR4
69.3IFNG, IL10, IL2, IL5
79.3IFNG, IL10, IL2, IL5
89.3IL5, IL6, TNF
99.2IFNG, IL6, TNF
109.2IFNG, TLR2, TLR4, TNF
119.1IL2, IL6, TLR2, TLR4
12
Show member pathways
9.1IFNG, IL10, IL2, TNF
139.1IFNG, IL2, IL5, IL6
149.0IFNG, IL10, IL2, IL6
159.0IL6, TLR2, TLR4, TNF
168.9IL10, IL6, TLR4, TNF
178.9IL10, IL6, TLR4, TNF
18
Show member pathways
8.9IFNG, IL6, TLR4, TNF
19
Show member pathways
8.9IFNG, IL10, TLR2, TLR4, TNF
208.9IFNG, IL10, IL2, IL5, TNF
218.9CCL5, IL6, TNF
228.9IFNG, IL2, IL6, TNF
23
Show member pathways
8.8CTLA4, IFNG, IL2, IL5, TNF
248.7TLR1, TLR2, TLR4, TLR6, TLR9
25
Show member pathways
8.7TLR1, TLR2, TLR4, TLR6, TLR9
268.6IFNG, IL2, IL6, TLR4, TNF
27
Show member pathways
8.6IFNG, IL10, IL2, IL6, TNF
288.4IFNG, IL10, IL6, TLR2, TLR4, TNF
298.4IFNG, IL10, IL6, TLR9, TNF
308.4IFNG, IL10, IL2, IL5, IL6, TNF
31
Show member pathways
8.4IFNG, IL10, IL2, IL5, IL6, TNF
328.4IFNG, IL10, IL2, IL5, IL6, TNF
33
Show member pathways
8.3TLR1, TLR2, TLR4, TLR6, TLR9, TNF
34
Show member pathways
8.3TLR1, TLR2, TLR4, TLR6, TLR9, TNF
35
Show member pathways
8.2CCL5, IFNG, IL10, IL2, IL5, IL6
36
Show member pathways
8.2IL2, IL5, TLR1, TLR2, TLR4, TLR6
378.1IFNG, IL10, IL2, IL6, TLR9, TNF
38
Show member pathways
8.1CCL5, IL10, IL2, IL5, IL6, TNF
398.1CCL5, IL10, IL2, IL5, IL6, TNF
40
Show member pathways
8.0CTLA4, IFNG, IL10, IL2, IL5, IL6
41
Show member pathways
7.9IFNG, IL6, TLR1, TLR2, TLR4, TLR6
427.8IFNG, IL10, IL6, TLR2, TLR4, TLR9
43
Show member pathways
7.7CCL5, IFNG, IL10, IL2, IL5, IL6
44
Show member pathways
7.7IL6, TLR1, TLR2, TLR4, TLR6, TLR9
45
Show member pathways
7.6IFNG, IL2, TLR1, TLR2, TLR4, TLR6
467.6CCL5, CTLA4, IFNG, IL6, TLR2, TLR4
477.5CTLA4, IL10, IL5, IL6, TLR2, TLR4
48
Show member pathways
7.5CCL5, IFNG, IL10, IL2, IL5, IL6
49
Show member pathways
7.4IL2, IL6, TLR1, TLR2, TLR4, TLR6
50
Show member pathways
7.4CTLA4, IFNG, IL10, IL2, IL5, IL6

GO Terms for genes affiliated with Filariasis

About this section

Cellular components related to Filariasis according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1Toll-like receptor 1-Toll-like receptor 2 protein complexGO:00353549.8TLR1, TLR2
2membrane raftGO:00451219.5TLR1, TLR2, TLR6, TNF
3phagocytic vesicle membraneGO:00306709.4TLR1, TLR2, TLR6
4external side of plasma membraneGO:00098979.3CTLA4, IFNG, IL6, TLR4, TNF
5extracellular spaceGO:00056157.3ALB, CCL5, CHIT1, IFNG, IL10, IL2
6extracellular regionGO:00055767.2ALB, CCL5, CHIT1, IFNG, IL2, IL5

Biological processes related to Filariasis according to GeneCards Suite gene sharing:

(show top 50)    (show all 93)
idNameGO IDScoreTop Affiliating Genes
1cellular response to lipoteichoic acidGO:007122310.8TLR2, TLR4
2cellular response to diacyl bacterial lipopeptideGO:007172610.7TLR2, TLR6
3detection of diacyl bacterial lipopeptideGO:004249610.7TLR2, TLR6
4negative regulation of interleukin-17 productionGO:003270010.7IFNG, TLR4
5nitric oxide metabolic processGO:004620910.7TLR2, TLR6
6positive regulation of interleukin-12 biosynthetic processGO:004508410.7IFNG, TLR4
7interleukin-1 beta secretionGO:005070210.7TLR4, TLR6
8cellular response to triacyl bacterial lipopeptideGO:007172710.7TLR1, TLR2
9detection of triacyl bacterial lipopeptideGO:004249510.7TLR1, TLR2
10macrophage activationGO:004211610.6TLR1, TLR4
11positive regulation of NLRP3 inflammasome complex assemblyGO:190022710.6TLR4, TLR6
12positive regulation of isotype switching to IgG isotypesGO:004830410.6IFNG, IL2
13negative regulation of B cell proliferationGO:003088910.6CTLA4, IL10
14response to bacterial lipoproteinGO:003249310.5TLR2, TLR6
15positive regulation of podosome assemblyGO:007180310.5IL5, TNF
16negative regulation of cytokine secretion involved in immune responseGO:000274010.5IL10, TNF
17positive regulation of tumor necrosis factor biosynthetic processGO:004253510.5TLR1, TLR4
18positive regulation of interleukin-8 biosynthetic processGO:004541610.5TLR4, TNF
19positive regulation of calcidiol 1-monooxygenase activityGO:006055910.5IFNG, TNF
20positive regulation of chemokine biosynthetic processGO:004508010.5IFNG, TNF
21cellular response to hepatocyte growth factor stimulusGO:003572910.5IL10, IL6
22positive regulation of interleukin-18 productionGO:003274110.5TLR2, TLR9
23positive regulation of membrane protein ectodomain proteolysisGO:005104410.5IFNG, TNF
24positive regulation of B cell proliferationGO:003089010.5IL2, IL5, TLR4
25negative regulation of interleukin-8 productionGO:003271710.5IL10, TLR9
26positive regulation of interferon-beta biosynthetic processGO:004535910.5TLR4, TLR9
27positive regulation of toll-like receptor signaling pathwayGO:003412310.5TLR2, TLR9
28neutrophil apoptotic processGO:000178110.4IFNG, IL6
29receptor biosynthetic processGO:003280010.4IL10, TNF
30positive regulation of vitamin D biosynthetic processGO:006055710.4IFNG, TNF
31positive regulation of MHC class II biosynthetic processGO:004534810.4IFNG, IL10, TLR4
32epithelial cell proliferation involved in salivary gland morphogenesisGO:006066410.3IL6, TNF
33T-helper 1 type immune responseGO:004208810.3TLR4, TLR6
34negative regulation of lipid storageGO:001088810.3IL6, TNF
35response to molecule of bacterial originGO:000223710.3IL10, TLR9
36I-kappaB phosphorylationGO:000725210.2TLR2, TLR4, TLR9
37positive regulation of interferon-gamma productionGO:003272910.2IL2, TLR4, TNF
38positive regulation of interleukin-6 biosynthetic processGO:004541010.2IFNG, TLR1, TLR6
39negative regulation of growth of symbiont in hostGO:004413010.2IFNG, IL10, TNF
40positive regulation of interferon-beta productionGO:003272810.2TLR2, TLR4, TLR9
41positive regulation of interleukin-10 productionGO:003273310.2TLR2, TLR4, TLR9
42positive regulation of immunoglobulin secretionGO:005102410.2IL2, IL5, IL6
43positive regulation of nitric-oxide synthase biosynthetic processGO:005177010.2TLR2, TLR4, TLR9
44positive regulation of fever generationGO:003162210.2CCL5, TNF
45defense response to protozoanGO:004283210.2IFNG, IL10, IL6
46response to bacteriumGO:000961710.1CHIT1, IL6, TLR4
47defense response to Gram-positive bacteriumGO:005083010.0IL6, TLR2, TNF
48positive regulation of JNK cascadeGO:004633010.0TLR4, TLR9, TNF
49humoral immune responseGO:000695910.0IFNG, IL6, TNF
50defense response to Gram-negative bacteriumGO:005082910.0IL6, TLR4, TLR9

Molecular functions related to Filariasis according to GeneCards Suite gene sharing:

(show all 7)
idNameGO IDScoreTop Affiliating Genes
1lipopolysaccharide receptor activityGO:000187510.6TLR2, TLR4
2Toll-like receptor 2 bindingGO:003566310.4TLR1, TLR6
3lipopeptide bindingGO:007172310.2TLR1, TLR2, TLR6
4receptor activityGO:00048729.8TLR1, TLR2, TLR4, TLR6
5growth factor activityGO:00080839.8IL10, IL2, IL5, IL6
6cytokine activityGO:00051259.0IFNG, IL10, IL2, IL5, IL6, TNF
7transmembrane signaling receptor activityGO:00048888.7TLR1, TLR2, TLR4, TLR6, TLR9

Sources for Filariasis

About this section
2CDC
6CNVD
10DGIdb
15ExPASy
16FDA
17FMA
27GTR
28HGMD
29HMDB
30ICD10
31ICD10 via Orphanet
32ICD9CM
33IUPHAR
34KEGG
37MedGen
39MeSH
40MESH via Orphanet
41MGI
44NCI
45NCIt
46NDF-RT
49NINDS
50Novoseek
52OMIM
53OMIM via Orphanet
57PubMed
58QIAGEN
63SNOMED-CT via Orphanet
67Tumor Gene Family of Databases
68UMLS
69UMLS via Orphanet